Data / Drug companies / Matrix Pharmacorp Private Limited
Matrix Pharmacorp Private Limited: 122 products in the FDA NDC directory, labeler code 84206
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Matrix Pharmacorp Private Limited (labeler code 84206) lists 122 products in the FDA National Drug Code Directory. By type: 122 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 28, 2026.
The request: Watch Matrix Pharmacorp Private Limited (FDA labeler code 84206): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 84206
- Products in commercial distribution
- 122
- Packages
- 122
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 5, Schedule V 2
- Started marketing in the last 12 months
- 6
- Earliest marketing start
- January 20, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 122 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 122 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 122 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sertraline hydrochloride | 84206-0122 | Powder | Bulk ingredients | August 28, 2026 |
| Celecoxib | 84206-0121 | Powder | Bulk ingredients | August 28, 2026 |
| Cevimeline hydrochloride | 84206-0117 | Powder | Bulk ingredients | August 28, 2026 |
| Sildenafil citrate | 84206-0120 | Powder | Bulk ingredients | June 29, 2026 |
| Gabapentin | 84206-0119 | Powder | Bulk ingredients | June 29, 2026 |
| Gabapentin | 84206-0118 | Powder | Bulk ingredients | June 29, 2026 |
| Sumatriptan succinate | 84206-0087 | Powder | Bulk ingredients | October 30, 2025 |
| Sertraline hydrochloride | 84206-0116 | Powder | Bulk ingredients | October 6, 2025 |
| Sertraline hydrochloride | 84206-0114 | Powder | Bulk ingredients | September 17, 2025 |
| Disulfiram | 84206-0115 | Powder | Bulk ingredients | August 14, 2025 |
| Phentolamine mesylate | 84206-0113 | Powder | Bulk ingredients | January 21, 2025 |
| Olsalazine sodium | 84206-0071 | Powder | Bulk ingredients | October 10, 2024 |
| Mafenide acetate | 84206-0062 | Powder | Bulk ingredients | October 10, 2024 |
| Esomeprazole magnesium | 84206-0044 | Powder | Bulk ingredients | October 9, 2024 |
| Escitalopram oxalate | 84206-0043 | Powder | Bulk ingredients | October 9, 2024 |
| Dolutegravir sodium | 84206-0031 | Powder | Bulk ingredients | October 8, 2024 |
| Citalopram hydrobromide | 84206-0022 | Powder | Bulk ingredients | October 8, 2024 |
| Carvedilol phosphate | 84206-0018 | Powder | Bulk ingredients | October 8, 2024 |
| Carvedilol | 84206-0017 | Powder | Bulk ingredients | October 4, 2024 |
| Abacavir sulfate | 84206-0002 | Powder | Bulk ingredients | October 4, 2024 |
| Pregabalin | 84206-0112 | Powder | Bulk ingredients | September 23, 2024 |
| Celecoxib | 84206-0111 | Powder | Bulk ingredients | September 23, 2024 |
| Atorvastatin calcium | 84206-0110 | Powder | Bulk ingredients | September 20, 2024 |
| Tenofovir disoproxil fumarate | 84206-0092 | Powder | Bulk ingredients | September 6, 2024 |
| Tenofovir disoproxil fumarate | 84206-0091 | Powder | Bulk ingredients | September 6, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.